NPS-846

N/A

Report date: 2022/08/23 20:00:44
NME

Base Information

Drug NameNPS-846
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonistsGlutamate receptors inhibitors
TargetsGlutamate receptorsGlutamate [NMDA] receptor
Therapy Area/IndicationsPainNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNps Pharmaceuticals, Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNps Pharmaceuticals, Inc
Active IndicationsN/A
Inactive IndicationsPainNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A